UCB S.A (UCBJY) Earnings Date & Reports

UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

UCBJY is expected to report earnings to fall 85.79% to 11 cents per share on February 28

Q4'23

Est.

$0.12

Q2'23

Missed

by $0.08

The last earnings report on July 27 showed earnings per share of 83 cents, missing the estimate of 91 cents. With 38.70K shares outstanding, the current market capitalization sits at 31.66B.

View a ticker or compare two or three

Compare

UCBJY